Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FG1DQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,695
Award facts
- Contract value 100% obligated
- $3,695.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,695.22 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen injections on April 28, 2025, with a completion date of April 29, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle running through December 2026. The pharmaceutical supply will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of competitively awarded contracts with the Defense Logistics Agency for military and veteran healthcare systems. The DLA Troop Support Medical contract vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling AmerisourceBergen to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. This delivery order for Zepbound, a diabetes management medication, represents a routine procurement from the company's established pharmaceutical inventory and reflects AmerisourceBergen's ongoing role as a primary pharmaceutical supplier for federal defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FG1DQ?
SPE2DB25FG1DQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 28, 2025.
How much is contract SPE2DB25FG1DQ worth?
The government has obligated $3,695 on SPE2DB25FG1DQ.
Is contract SPE2DB25FG1DQ an order under another contract?
Yes. SPE2DB25FG1DQ is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FG1DQ competed?
The extent of competition for SPE2DB25FG1DQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award